Cognitive Outcomes During Adjunctive Cenobamate Treatment in Patients with Drug-Resistant Epilepsy: An Interim Analysis of a Prospective Observational Study.
AIM To examine the impact of cenobamate (CNB) treatment on cognitive function in patients with epilepsy. METHODS We assessed seventeen patients before (T0) and after treatment (T1) with CNB 200 mg/day (duration: median 5.6 months, range 3.3-11.6 months). All patients underwent a neuropsychological test battery coveri...